{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T10:36:15Z","timestamp":1776335775547,"version":"3.51.2"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T00:00:00Z","timestamp":1588982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T00:00:00Z","timestamp":1588982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00345-020-03233-9","type":"journal-article","created":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T09:02:31Z","timestamp":1589014951000},"page":"953-962","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Efficacy and safety of oral phosphodiesterase 5 inhibitors for erectile dysfunction: a network meta-analysis and multicriteria decision analysis"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5438-1916","authenticated-orcid":false,"given":"Camilla R.","family":"Madeira","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-8608","authenticated-orcid":false,"given":"Fernanda S.","family":"Tonin","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5918-4738","authenticated-orcid":false,"given":"Mariana M.","family":"Fachi","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9723-584X","authenticated-orcid":false,"given":"Helena H.","family":"Borba","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0102-2995","authenticated-orcid":false,"given":"Vinicius L.","family":"Ferreira","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0927-3120","authenticated-orcid":false,"given":"Leticia P.","family":"Leonart","sequence":"additional","affiliation":[]},{"given":"Aline F.","family":"Bonetti","sequence":"additional","affiliation":[]},{"given":"Rogerio P.","family":"Moritz","sequence":"additional","affiliation":[]},{"given":"Angela C. L. B.","family":"Trindade","sequence":"additional","affiliation":[]},{"given":"Alan G.","family":"Gon\u00e7alves","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8529-9595","authenticated-orcid":false,"given":"Fernando","family":"Fernandez-Llimos","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7049-4363","authenticated-orcid":false,"given":"Roberto","family":"Pontarolo","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,5,9]]},"reference":[{"issue":"1","key":"3233_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/smrj.2","volume":"1","author":"I Eardley","year":"2013","unstructured":"Eardley I (2013) The incidence, prevalence, and natural history of erectile dysfunction. Sex Med Rev 1(1):3\u201316. https:\/\/doi.org\/10.1002\/smrj.2","journal-title":"Sex Med Rev"},{"issue":"4","key":"3233_CR2","doi-asserted-by":"publisher","first-page":"e13078","DOI":"10.1111\/ijcp.13078","volume":"72","author":"I Goldstein","year":"2018","unstructured":"Goldstein I, Chambers R, Tang W, Stecher V, Hassan T (2018) Real-world observational results from a database of 48 million men in the United States: relationship of cardiovascular disease, diabetes mellitus and depression with age and erectile dysfunction. Int J Clin Pract 72(4):e13078. https:\/\/doi.org\/10.1111\/ijcp.13078","journal-title":"Int J Clin Pract"},{"issue":"2","key":"3233_CR3","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jsxm.2015.12.034","volume":"13","author":"MP McCabe","year":"2016","unstructured":"McCabe MP, Sharlip ID, Lewis R, Atalla E, Balon R, Fisher AD, Laumann E, Lee SW, Segraves RT (2016) Incidence and prevalence of sexual dysfunction in women and men: a consensus statement from the fourth international consultation on sexual medicine 2015. J Sex Med 13(2):144\u2013152. https:\/\/doi.org\/10.1016\/j.jsxm.2015.12.034","journal-title":"J Sex Med"},{"key":"3233_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2018.05.004","author":"AL Burnett","year":"2018","unstructured":"Burnett AL, Nehra A, Breau RH, Culkin DJ, Faraday MM, Hakim LS, Heidelbaugh J, Khera M, McVary KT, Miner MM, Nelson CJ, Sadeghi-Nejad H, Seftel AD, Shindel AW (2018) Erectile dysfunction: AUA guideline. J Urol. https:\/\/doi.org\/10.1016\/j.juro.2018.05.004","journal-title":"J Urol"},{"issue":"4","key":"3233_CR5","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.jsxm.2016.01.016","volume":"13","author":"K Hatzimouratidis","year":"2016","unstructured":"Hatzimouratidis K, Salonia A, Adaikan G, Buvat J, Carrier S, El-Meliegy A, McCullough A, Torres LO, Khera M (2016) Pharmacotherapy for erectile dysfunction: recommendations from the fourth international consultation for sexual medicine (ICSM 2015). J Sex Med 13(4):465\u2013488. https:\/\/doi.org\/10.1016\/j.jsxm.2016.01.016","journal-title":"J Sex Med"},{"issue":"13","key":"3233_CR6","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1111\/bph.14205","volume":"175","author":"KE Andersson","year":"2018","unstructured":"Andersson KE (2018) PDE5 inhibitors\u2014pharmacology and clinical applications 20 years after sildenafil discovery. Br J Pharmacol 175(13):2554\u20132565. https:\/\/doi.org\/10.1111\/bph.14205","journal-title":"Br J Pharmacol"},{"issue":"11","key":"3233_CR7","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nrurol.2010.165","volume":"7","author":"V Palit","year":"2010","unstructured":"Palit V, Eardley I (2010) An update on new oral PDE5 inhibitors for the treatment of erectile dysfunction. Nat Rev Urol 7(11):603\u2013609. https:\/\/doi.org\/10.1038\/nrurol.2010.165","journal-title":"Nat Rev Urol"},{"issue":"6","key":"3233_CR8","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1111\/andr.12255","volume":"4","author":"G Corona","year":"2016","unstructured":"Corona G, Rastrelli G, Burri A, Serra E, Gianfrilli D, Mannucci E, Jannini EA, Maggi M (2016) First-generation phosphodiesterase type 5 inhibitors dropout: a comprehensive review and meta-analysis. Andrology 4(6):1002\u20131009. https:\/\/doi.org\/10.1111\/andr.12255","journal-title":"Andrology"},{"issue":"4","key":"3233_CR9","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.eururo.2015.04.007","volume":"68","author":"P Verze","year":"2015","unstructured":"Verze P, Cai T, Palmieri A, Mirone V (2015) 17 years of clinical experience with phosphodiesterase type 5 inhibitors: what do we have yet to learn? Eur Urol 68(4):681\u2013682. https:\/\/doi.org\/10.1016\/j.eururo.2015.04.007","journal-title":"Eur Urol"},{"issue":"5","key":"3233_CR10","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.eururo.2013.01.012","volume":"63","author":"J Yuan","year":"2013","unstructured":"Yuan J, Zhang R, Yang Z, Lee J, Liu Y, Tian J, Qin X, Ren Z, Ding H, Chen Q, Mao C, Tang J (2013) Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis. Eur Urol 63(5):902\u2013912. https:\/\/doi.org\/10.1016\/j.eururo.2013.01.012","journal-title":"Eur Urol"},{"issue":"4","key":"3233_CR11","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.eururo.2015.03.031","volume":"68","author":"L Chen","year":"2015","unstructured":"Chen L, Staubli SE, Schneider MP, Kessels AG, Ivic S, Bachmann LM, Kessler TM (2015) Phosphodiesterase 5 inhibitors for the treatment of erectile dysfunction: a trade-off network meta-analysis. Eur Urol 68(4):674\u2013680. https:\/\/doi.org\/10.1016\/j.eururo.2015.03.031","journal-title":"Eur Urol"},{"issue":"11","key":"3233_CR12","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","volume":"162","author":"B Hutton","year":"2015","unstructured":"Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, Ioannidis JPA, Straus S (2015) The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med 162(11):777\u2013784","journal-title":"Ann Intern Med"},{"issue":"3","key":"3233_CR13","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1371\/journal.pmed.0040078","volume":"4","author":"D Moher","year":"2007","unstructured":"Moher D, Tetzlaff J, Tricco AC, Sampson M, Altman DG (2007) Epidemiology and reporting characteristics of systematic reviews. PLoS Med 4(3):e78. https:\/\/doi.org\/10.1371\/journal.pmed.0040078","journal-title":"PLoS Med"},{"key":"3233_CR14","volume-title":"Cochrane handbook for systematic reviews of interventions version 5.1.0","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Green S (2011) Cochrane handbook for systematic reviews of interventions version 5.1.0. Cochrane, London"},{"issue":"1","key":"3233_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"AR Jadad","year":"1996","unstructured":"Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17(1):1\u201312","journal-title":"Control Clin Trials"},{"issue":"3","key":"3233_CR16","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1093\/ije\/dys041","volume":"41","author":"RM Turner","year":"2012","unstructured":"Turner RM, Davey J, Clarke MJ, Thompson SG, Higgins JP (2012) Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews. Int J Epidemiol 41(3):818\u2013827. https:\/\/doi.org\/10.1093\/ije\/dys041","journal-title":"Int J Epidemiol"},{"issue":"5","key":"3233_CR17","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1177\/0272989X12455847","volume":"33","author":"S Dias","year":"2013","unstructured":"Dias S, Welton NJ, Sutton AJ, Caldwell DM, Lu G, Ades AE (2013) Evidence synthesis for decision making 4: inconsistency in networks of evidence based on randomized controlled trials. Med Decis Mak 33(5):641\u2013656. https:\/\/doi.org\/10.1177\/0272989X12455847","journal-title":"Med Decis Mak"},{"key":"3233_CR18","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/1741-7015-11-159","volume":"11","author":"JP Jansen","year":"2013","unstructured":"Jansen JP, Naci H (2013) Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers. BMC Med 11:159. https:\/\/doi.org\/10.1186\/1741-7015-11-159","journal-title":"BMC Med"},{"issue":"7\u20138","key":"3233_CR19","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/sim.3767","volume":"29","author":"S Dias","year":"2010","unstructured":"Dias S, Welton NJ, Caldwell DM, Ades AE (2010) Checking consistency in mixed treatment comparison meta-analysis. Stat Med 29(7\u20138):932\u2013944. https:\/\/doi.org\/10.1002\/sim.3767","journal-title":"Stat Med"},{"key":"3233_CR20","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.dss.2012.10.005","volume":"55","author":"G van Valkenhoef","year":"2013","unstructured":"van Valkenhoef G, Tervonen T, Zwinkels T, de Brock B, Hillege HL (2013) ADDIS: a decision support system for evidence-based medicine. Decis Support Syst 55:459\u2013475","journal-title":"Decis Support Syst"},{"key":"3233_CR21","volume-title":"R: a language and environment for statistical computing","author":"RC Team","year":"2013","unstructured":"Team RC (2013) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna"},{"key":"3233_CR22","doi-asserted-by":"crossref","unstructured":"Bastian M, Heymann S, Jacomy M (2009) Gephi: an open source software for exploring and manipulating networks. International AAAI Conference on Weblogs and Social Media","DOI":"10.1609\/icwsm.v3i1.13937"},{"issue":"4","key":"3233_CR23","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jclinepi.2011.09.005","volume":"65","author":"G van Valkenhoef","year":"2012","unstructured":"van Valkenhoef G, Tervonen T, Zhao J, de Brock B, Hillege HL, Postmus D (2012) Multicriteria benefit\u2013risk assessment using network meta-analysis. J Clin Epidemiol 65(4):394\u2013403. https:\/\/doi.org\/10.1016\/j.jclinepi.2011.09.005","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"3233_CR24","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1002\/sim.4194","volume":"30","author":"T Tervonen","year":"2011","unstructured":"Tervonen T, van Valkenhoef G, Buskens E, Hillege HL, Postmus D (2011) A stochastic multicriteria model for evidence-based decision making in drug benefit\u2013risk analysis. Stat Med 30(12):1419\u20131428. https:\/\/doi.org\/10.1002\/sim.4194","journal-title":"Stat Med"},{"key":"3233_CR25","doi-asserted-by":"publisher","unstructured":"Jiann BP (2014) Re: JinQiu Yuan, RenJie Zhang, ZuYao Yang, et al. Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis. Eur Urol 2013;63:902\u201312. Eur Urol 65 (3):e40. https:\/\/doi.org\/10.1016\/j.eururo.2013.10.014","DOI":"10.1016\/j.eururo.2013.10.014"},{"issue":"4","key":"3233_CR26","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.juro.2013.06.077","volume":"190","author":"A Seftel","year":"2013","unstructured":"Seftel A (2013) Re: Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis. J Urol 190(4):1340. https:\/\/doi.org\/10.1016\/j.juro.2013.06.077","journal-title":"J Urol"},{"issue":"10","key":"3233_CR27","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s11255-017-1644-5","volume":"49","author":"B Gong","year":"2017","unstructured":"Gong B, Ma M, Xie W, Yang X, Huang Y, Sun T, Luo Y, Huang J (2017) Direct comparison of tadalafil with sildenafil for the treatment of erectile dysfunction: a systematic review and meta-analysis. Int Urol Nephrol 49(10):1731\u20131740. https:\/\/doi.org\/10.1007\/s11255-017-1644-5","journal-title":"Int Urol Nephrol"},{"issue":"9","key":"3233_CR28","doi-asserted-by":"publisher","first-page":"650","DOI":"10.7326\/0003-4819-151-9-200911030-00150","volume":"151","author":"A Tsertsvadze","year":"2009","unstructured":"Tsertsvadze A, Fink HA, Yazdi F, MacDonald R, Bella AJ, Ansari MT, Garritty C, Soares-Weiser K, Daniel R, Sampson M, Fox S, Moher D, Wilt TJ (2009) Oral phosphodiesterase-5 inhibitors and hormonal treatments for erectile dysfunction: a systematic review and meta-analysis. Ann Intern Med 151(9):650\u2013661. https:\/\/doi.org\/10.7326\/0003-4819-151-9-200911030-00150","journal-title":"Ann Intern Med"},{"issue":"1","key":"3233_CR29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.mcna.2010.08.016","volume":"95","author":"M Albersen","year":"2011","unstructured":"Albersen M, Mwamukonda KB, Shindel AW, Lue TF (2011) Evaluation and treatment of erectile dysfunction. Med Clin N Am 95(1):201\u2013212. https:\/\/doi.org\/10.1016\/j.mcna.2010.08.016","journal-title":"Med Clin N Am"},{"issue":"2","key":"3233_CR30","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.sxmr.2017.08.001","volume":"6","author":"FA Yafi","year":"2018","unstructured":"Yafi FA, Sharlip ID, Becher EF (2018) Update on the safety of phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction. Sex Med Rev 6(2):242\u2013252. https:\/\/doi.org\/10.1016\/j.sxmr.2017.08.001","journal-title":"Sex Med Rev"},{"issue":"4","key":"3233_CR31","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.urology.2007.12.025","volume":"71","author":"AR McCullough","year":"2008","unstructured":"McCullough AR, Steidle CP, Klee B, Tseng LJ (2008) 1389-Randomized, double-blind, crossover trial of sildenafil in men with mild to moderate erectile dysfunction: efficacy at 8 and 12 hours postdose. Urology 71(4):686\u2013692. https:\/\/doi.org\/10.1016\/j.urology.2007.12.025","journal-title":"Urology"},{"issue":"1","key":"3233_CR32","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0090-4295(03)00359-5","volume":"62","author":"H Porst","year":"2003","unstructured":"Porst H, Padma-Nathan H, Giuliano F, Anglin G, Varanese L, Rosen R (2003) 2289-Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial. Urology 62(1):121\u2013125 (discussion 125\u2013126)","journal-title":"Urology"},{"issue":"2","key":"3233_CR33","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.eururo.2011.03.025","volume":"60","author":"C Zhao","year":"2011","unstructured":"Zhao C, Kim SW, Yang DY, Kim JJ, Park NC, Lee SW, Paick JS, Ahn TY, Min KS, Park K, Park JK (2011) 905-Efficacy and safety of once-daily dosing of udenafil in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial. Eur Urol 60(2):380\u2013387. https:\/\/doi.org\/10.1016\/j.eururo.2011.03.025","journal-title":"Eur Urol"},{"issue":"11","key":"3233_CR34","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/sj.sc.3101617","volume":"42","author":"G Del Popolo","year":"2004","unstructured":"Del Popolo G, Li Marzi V, Mondaini N, Lombardi G (2004) 2093-Time\/duration effectiveness of sildenafil versus tadalafil in the treatment of erectile dysfunction in male spinal cord-injured patients. Spinal Cord 42(11):643\u2013648. https:\/\/doi.org\/10.1038\/sj.sc.3101617","journal-title":"Spinal Cord"},{"issue":"2","key":"3233_CR35","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1743-6109.2004.04025.x","volume":"1","author":"F Montorsi","year":"2004","unstructured":"Montorsi F, Padma-Nathan H, Buvat J, Schwaibold H, Beneke M, Ulbrich E, Bandel TJ, Porst H (2004) 1796-Earliest time to onset of action leading to successful intercourse with vardenafil determined in an at-home setting: a randomized, double-blind, placebo-controlled trial. J Sex Med 1(2):168\u2013178. https:\/\/doi.org\/10.1111\/j.1743-6109.2004.04025.x","journal-title":"J Sex Med"},{"issue":"2","key":"3233_CR36","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.juro.2014.12.101","volume":"194","author":"WJ Hellstrom","year":"2015","unstructured":"Hellstrom WJ, Kaminetsky J, Belkoff LH, Goldstein I, Tursi JP, Uy J, Peterson CA, Bowden CH, Day WW (2015) 245-Efficacy of avanafil 15 minutes after dosing in men with erectile dysfunction: a randomized, double-blind. Placebo Controlled Study J Urol 194(2):485\u2013492. https:\/\/doi.org\/10.1016\/j.juro.2014.12.101","journal-title":"Placebo Controlled Study J Urol"},{"issue":"2","key":"3233_CR37","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1517\/14740338.2016.1131818","volume":"15","author":"E Ventimiglia","year":"2016","unstructured":"Ventimiglia E, Capogrosso P, Montorsi F, Salonia A (2016) The safety of phosphodiesterase type 5 inhibitors for erectile dysfunction. Expert Opin Drug Saf 15(2):141\u2013152. https:\/\/doi.org\/10.1517\/14740338.2016.1131818","journal-title":"Expert Opin Drug Saf"},{"issue":"6","key":"3233_CR38","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/ijir.2014.15","volume":"26","author":"K Hatzimouratidis","year":"2014","unstructured":"Hatzimouratidis K, Buvat J, Buttner H, Vendeira PA, Moncada I, Boehmer M, Henneges C, Boess FG (2014) 345-Psychosocial outcomes after initial treatment of erectile dysfunction with tadalafil once daily, tadalafil on demand or sildenafil citrate on demand: results from a randomized, open-label study. Int J Impot Res 26(6):223\u2013229. https:\/\/doi.org\/10.1038\/ijir.2014.15","journal-title":"Int J Impot Res"},{"issue":"6","key":"3233_CR39","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1111\/jsm.12130","volume":"10","author":"J Buvat","year":"2013","unstructured":"Buvat J, Buttner H, Hatzimouratidis K, Vendeira PA, Moncada I, Boehmer M, Henneges C, Boess FG (2013) 559-Adherence to initial PDE-5 inhibitor treatment: randomized open-label study comparing tadalafil once a day, tadalafil on demand, and sildenafil on demand in patients with erectile dysfunction. J Sex Med 10(6):1592\u20131602. https:\/\/doi.org\/10.1111\/jsm.12130","journal-title":"J Sex Med"},{"issue":"10","key":"3233_CR40","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.jsxm.2018.05.021","volume":"15","author":"JP Mulhall","year":"2018","unstructured":"Mulhall JP, Giraldi A, Hackett G, Hellstrom WJG, Jannini EA, Rubio-Aurioles E, Trost L, Hassan TA (2018) The 2018 revision to the process of care model for management of erectile dysfunction. J Sex Med 15(10):1434\u20131445. https:\/\/doi.org\/10.1016\/j.jsxm.2018.05.021","journal-title":"J Sex Med"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-020-03233-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-020-03233-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-020-03233-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T21:24:32Z","timestamp":1696109072000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-020-03233-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,9]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["3233"],"URL":"https:\/\/doi.org\/10.1007\/s00345-020-03233-9","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,9]]},"assertion":[{"value":"13 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}